ORIC
Income statement / Annual
Last year (2023), ORIC Pharmaceuticals, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, ORIC Pharmaceuticals, Inc.'s net income was -$100.70 M.
See ORIC Pharmaceuticals, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$1.03 M |
$966,000.00 |
$897,000.00 |
$970,000.00 |
$1.00 M |
$900,000.00 |
$900,000.00 |
| Gross Profit |
-$1.03 M |
-$966,000.00 |
-$897,000.00 |
-$970,000.00 |
-$1.00 M |
-$900,000.00 |
-$900,000.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$85.17 M
|
$61.68 M
|
$56.86 M
|
$35.92 M
|
$22.84 M
|
$19.03 M
|
$19.13 M
|
| General & Administrative
Expenses |
$25.61 M
|
$25.09 M
|
$22.01 M
|
$13.42 M
|
$5.73 M
|
$3.35 M
|
$3.42 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$900,000.00
|
| Selling, General &
Administrative Expenses |
$25.61 M
|
$25.09 M
|
$22.01 M
|
$13.42 M
|
$5.73 M
|
$3.35 M
|
$2.52 M
|
| Other Expenses |
$0.00 |
$5.00 M |
$15,000.00 |
$177,000.00 |
$289,000.00 |
$233,000.00 |
$0.00 |
| Operating Expenses |
$110.78 M |
$86.77 M |
$78.87 M |
$49.34 M |
$28.57 M |
$22.37 M |
$21.64 M |
| Cost And Expenses |
$110.78 M |
$86.77 M |
$78.87 M |
$49.34 M |
$28.57 M |
$22.37 M |
$22.54 M |
| Interest Income |
$10.08 M |
$2.65 M |
$141,000.00 |
$306,000.00 |
$1.40 M |
$775,000.00 |
$251,000.00 |
| Interest Expense |
$0.00 |
$2.65 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$1.03 M
|
$966,000.00
|
$897,000.00
|
$970,000.00
|
$1.00 M
|
$900,000.00
|
$900,000.00
|
| EBITDA |
-$109.75 M
|
-$91.77 M
|
-$77.97 M
|
-$74.19 M
|
-$27.54 M
|
-$20.46 M
|
-$21.13 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$10.08 M
|
$2.65 M
|
$156,000.00
|
$483,000.00
|
$1.69 M
|
$1.01 M
|
$512,000.00
|
| Income Before Tax |
-$100.70 M |
-$89.12 M |
-$78.72 M |
-$73.70 M |
-$26.88 M |
-$21.36 M |
-$22.03 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
$2.36 M |
-$1.04 M |
$23.57 M |
-$1.40 M |
-$1.01 M |
$0.00 |
| Net Income |
-$100.70 M |
-$91.48 M |
-$77.68 M |
-$97.27 M |
-$25.49 M |
-$21.36 M |
-$22.03 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-1.96 |
-2.31 |
-2.05 |
-4.43 |
-0.85 |
-1.12 |
-0.74 |
| EPS Diluted |
-1.96 |
-2.31 |
-2.05 |
-4.43 |
-0.85 |
-1.12 |
-0.74 |
| Weighted Average Shares
Out |
$51.45 M
|
$39.66 M
|
$37.95 M
|
$21.94 M
|
$29.90 M
|
$19.14 M
|
$29.90 M
|
| Weighted Average Shares
Out Diluted |
$51.45 M
|
$39.66 M
|
$37.95 M
|
$21.94 M
|
$29.90 M
|
$19.14 M
|
$29.90 M
|
| Link |
|
|
|
|
|
|
|
